Rodewald Lance E, Orenstein Walter A, Mason Dean D, Cochi Stephen L
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Clin Infect Dis. 2006 Mar 1;42 Suppl 3:S104-10. doi: 10.1086/499587.
Although immunization is one of the great public health achievements, continued success depends on an available supply of the vaccines that are recommended for routine use. Beginning in 2000, the United States experienced vaccine supply disruptions of unprecedented scope and magnitude. Although most of the supply disruptions have been resolved, it appears that a fragile vaccine supply will be part of the immunization environment in the United States for the foreseeable future. Here, we describe the perspective of the Centers for Disease Control and Prevention on the recent supply disruptions and the methods used to manage vaccine shortages. The present article focuses on routine pediatric vaccines, including influenza virus vaccine.
尽管免疫接种是公共卫生领域的重大成就之一，但持续取得成功依赖于有可供常规使用的推荐疫苗供应。从2000年开始，美国经历了前所未有的疫苗供应中断，其范围和规模巨大。尽管大部分供应中断问题已得到解决，但在可预见的未来，脆弱的疫苗供应似乎仍将是美国免疫接种环境的一部分。在此，我们描述疾病控制与预防中心对近期供应中断情况的看法以及用于管理疫苗短缺的方法。本文重点关注常规儿科疫苗，包括流感病毒疫苗。
